You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 29 No. 6, December 1973 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati
What's this?

Negative Sodium Balance in Lithium Carbonate Toxicity

Evidence of Mineralocorticoid Blockade

Leslie Baer, MD; Alexander H. Glassman, MD; Suham Kassir

Arch Gen Psychiatry. 1973;29(6):823-827.


Abstract

The patients reported developed lithium carbonate toxicity while being maintained on a constant sodium and fluid intake. Negative sodium balance was observed in both patients coincident with the onset of lithium carbonate toxicity. Negative sodium balance was also observed in lithium carbonate-toxic rats.

The renal response to the mineralocorticoid deoxycorticosterone acetate (DOC) was evaluated in groups of control and lithium carbonate-treated rats in order to further explore the renal mechanisms involved in lithium carbonate toxicity. In established lithium carbonate toxicity, a blunted response to the sodium retaining properties of DOC was present.

Accordingly, these observations demonstrate a pathogenic cycle in lithium carbonate toxicity. Mineralocorticoid blockade induced by already toxic concentrations of lithium carbonate promotes renal sodium wasting which in turn leads to further lithium carbonate retention and increased toxicity.



Author Affiliations

New York

From the departments of medicine and psychiatry, Columbia University College of Physicians & Surgeons and the New York State Psychiatric Institute, New York.


Footnotes

Accepted for publication July 24, 1973.

Reprint requests to 722 W 168th St, New York, NY 10032 (Dr. Baer).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Lithium-induced NDI in rats is associated with loss of {alpha}-ENaC regulation by aldosterone in CCD
Nielsen et al.
Am. J. Physiol. Renal Physiol. 2006;290:F1222-F1233.
ABSTRACT | FULL TEXT  

Segment-specific ENaC downregulation in kidney of rats with lithium-induced NDI
Nielsen et al.
Am. J. Physiol. Renal Physiol. 2003;285:F1198-F1209.
ABSTRACT | FULL TEXT  

Chronic Lithium Treatment Inhibits Amiloride-Sensitive Sodium Transport in the Rat Distal Nephron
Thomsen et al.
J. Pharmacol. Exp. Ther. 1999;289:443-447.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1973 American Medical Association. All Rights Reserved.